EUVIMEDEUVIMED entdecken
Crossref

Pharmacologic Strategies, Clinical Outcomes, and Safety Considerations in Intrauterine Insemination: A Focused Narrative Review

Shima Mohammadian, Ramesh Baradaran Bagheri

International Journal of Drug Research in Clinics · 15.12.2025 · 3 · e24

DOI: 10.34172/ijdrc.2025.e24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Research in Clinics, online erschienen am 15.12.2025. Verfasst von Shima Mohammadian und 1 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intrauterine insemination (IUI) is a widely used first-line assisted reproductive technology (ART) in which pharmacologic interventions largely determine efficacy and safety. Therefore, this study aimed to synthesize and critically evaluate evidence on pharmacologic strategies utilized in IUI, focusing on clinical outcomes, safety profiles, and unresolved clinical controversies.

Methods

A narrative review was conducted using PubMed, Scopus, and Web of Science to identify English-language studies (2000–2025) addressing the pharmacologic management of IUI cycles. Randomized controlled trials, systematic reviews, meta-analyses, and major clinical guidelines were prioritized in this review.

Results

Based on the findings, ovarian stimulation agents, such as clomiphene citrate, aromatase inhibitors, and gonadotropins, demonstrated differing efficacy–risk profiles. Notably, it was revealed that mild stimulation protocols provide the most favorable balance between pregnancy rates and complications. Nonetheless, evidence supporting emerging technologies (e.g., artificial intelligence-guided protocols and biomarker-driven dosing) remains preliminary.

Conclusion

Overall, pharmacologic management is central to IUI success. Individualized, evidence-based stimulation strategies emphasizing safety over maximal follicular recruitment should guide clinical practice.

Zitieren

APA

Mohammadian, S., & Bagheri, R. B. (2025). Pharmacologic Strategies, Clinical Outcomes, and Safety Considerations in Intrauterine Insemination: A Focused Narrative Review. International Journal of Drug Research in Clinics, 3, e24. https://doi.org/10.34172/ijdrc.2025.e24

Vancouver

Mohammadian S, Bagheri RB. Pharmacologic Strategies, Clinical Outcomes, and Safety Considerations in Intrauterine Insemination: A Focused Narrative Review. International Journal of Drug Research in Clinics. 2025;3:e24. doi:10.34172/ijdrc.2025.e24

BibTeX
@article{Mohammadian2025,
  author = {Mohammadian, Shima and Bagheri, Ramesh Baradaran},
  title = {Pharmacologic Strategies, Clinical Outcomes, and Safety Considerations in Intrauterine Insemination: A Focused Narrative Review},
  journal = {International Journal of Drug Research in Clinics},
  year = {2025},
  volume = {3},
  pages = {e24},
  doi = {10.34172/ijdrc.2025.e24}
}
Kostenlos starten →